Atallah, E <br/><br/>
Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.  [electronic resource] 

 -  Leukemia  Jun 2008 
 - 1295-8 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2405054  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia, Refractory--classification<br/>Anemia, Sideroblastic--classification<br/>Female<br/>Humans<br/>Janus Kinase 2--genetics<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--classification<br/>Myeloproliferative Disorders--classification<br/>Point Mutation--genetics<br/>Prognosis<br/>Survival Rate<br/>Thrombocytosis--classification<br/>World Health Organization